Page last updated: 2024-11-04

ponalrestat and Diabetic Retinopathy

ponalrestat has been researched along with Diabetic Retinopathy in 6 studies

Diabetic Retinopathy: Disease of the RETINA as a complication of DIABETES MELLITUS. It is characterized by the progressive microvascular complications, such as ANEURYSM, interretinal EDEMA, and intraocular PATHOLOGIC NEOVASCULARIZATION.

Research Excerpts

ExcerptRelevanceReference
" Ponalrestat administration at a dosage of 600 mg daily for 12 months has no significant effect on the course of minimal retinopathy in diabetic patients."2.67The effects of an aldose reductase inhibitor on the progression of diabetic retinopathy. ( Barendsen, BC; Hooymans, JM; Tromp, A; van Doormaal, JJ, 1991)

Research

Studies (6)

TimeframeStudies, this research(%)All Research%
pre-19903 (50.00)18.7374
1990's3 (50.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Lightman, S1
Kamijo, M1
Cherian, PV1
Sima, AA2
Tromp, A1
Hooymans, JM1
Barendsen, BC1
van Doormaal, JJ1
Chakrabarti, S1
Hotta, N1
Sakamoto, N1
Kador, PF1
Kinoshita, JH1
Sharpless, NE1

Reviews

3 reviews available for ponalrestat and Diabetic Retinopathy

ArticleYear
Does aldose reductase have a role in the development of the ocular complications of diabetes?
    Eye (London, England), 1993, Volume: 7 ( Pt 2)

    Topics: Aldehyde Reductase; Animals; Cataract; Clinical Trials as Topic; Corneal Diseases; Diabetes Mellitus

1993
[Clinical application of aldose reductase inhibitors--prevention and therapy of diabetic complications].
    Nihon rinsho. Japanese journal of clinical medicine, 1987, Volume: 45, Issue:12

    Topics: Aldehyde Reductase; Blood Glucose; Diabetes Complications; Diabetes Mellitus; Diabetic Nephropathies

1987
Aldose reductase inhibitors: a potential new class of agents for the pharmacological control of certain diabetic complications.
    Journal of medicinal chemistry, 1985, Volume: 28, Issue:7

    Topics: Aldehyde Reductase; Animals; Binding Sites; Blood Glucose; Cataract; Chemical Phenomena; Chemistry;

1985

Trials

1 trial available for ponalrestat and Diabetic Retinopathy

ArticleYear
The effects of an aldose reductase inhibitor on the progression of diabetic retinopathy.
    Documenta ophthalmologica. Advances in ophthalmology, 1991, Volume: 78, Issue:3-4

    Topics: Adolescent; Adult; Aldehyde Reductase; Diabetes Mellitus, Type 1; Diabetes Mellitus, Type 2; Diabeti

1991

Other Studies

2 other studies available for ponalrestat and Diabetic Retinopathy

ArticleYear
The preventive effect of aldose reductase inhibition on diabetic optic neuropathy in the BB/W-rat.
    Diabetologia, 1993, Volume: 36, Issue:10

    Topics: Aldehyde Reductase; Animals; Atrophy; Axons; Diabetes Mellitus, Type 1; Diabetic Neuropathies; Diabe

1993
Effect of aldose reductase inhibition and insulin treatment on retinal capillary basement membrane thickening in BB rats.
    Diabetes, 1989, Volume: 38, Issue:9

    Topics: Aldehyde Reductase; Animals; Basement Membrane; Blood Glucose; Capillaries; Chronic Disease; Diabeti

1989